These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 10465407)

  • 1. Synthesis and biological activity of high-affinity retinoic acid receptor antagonists.
    Johnson AT; Wang L; Standeven AM; Escobar M; Chandraratna RA
    Bioorg Med Chem; 1999 Jul; 7(7):1321-38. PubMed ID: 10465407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retinoid X receptor agonist elevation of serum triglycerides in rats by potentiation of retinoic acid receptor agonist induction or by action as single agents.
    Standeven AM; Thacher SM; Yuan YD; Escobar M; Vuligonda V; Beard RL; Chandraratna RA
    Biochem Pharmacol; 2001 Dec; 62(11):1501-9. PubMed ID: 11728386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of highly potent retinoic acid receptor alpha-selective antagonists.
    Teng M; Duong TT; Johnson AT; Klein ES; Wang L; Khalifa B; Chandraratna RA
    J Med Chem; 1997 Aug; 40(16):2445-51. PubMed ID: 9258350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 4-[3-(5,6,7,8-Tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)phenyl]benzoic acid and heterocyclic-bridged analogues are novel retinoic acid receptor subtype and retinoid X receptor alpha agonists.
    Dawson MI; Jong L; Hobbs PD; Xiao D; Feng KC; Chao WR; Pan C; Fontana JA; Zhang XK
    Bioorg Med Chem Lett; 2000 Jun; 10(12):1311-3. PubMed ID: 10890153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and structure-activity relationships of stilbene retinoid analogs substituted with heteroaromatic carboxylic acids.
    Beard RL; Chandraratna RA; Colon DF; Gillett SJ; Henry E; Marler DK; Song T; Denys L; Garst ME; Arefieg T
    J Med Chem; 1995 Jul; 38(15):2820-9. PubMed ID: 7636843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retinoic acid receptor alpha expression correlates with retinoid-induced growth inhibition of human breast cancer cells regardless of estrogen receptor status.
    Fitzgerald P; Teng M; Chandraratna RA; Heyman RA; Allegretto EA
    Cancer Res; 1997 Jul; 57(13):2642-50. PubMed ID: 9205071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent developments in receptor-selective retinoids.
    Nagpal S; Chandraratna RA
    Curr Pharm Des; 2000 Jun; 6(9):919-31. PubMed ID: 10828316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of the differential coregulator binding signatures of the Retinoic Acid Receptor subtypes upon (ant)agonist action.
    Miro Estruch I; Melchers D; Houtman R; de Haan LHJ; Groten JP; Louisse J; Rietjens IMCM
    Biochim Biophys Acta Proteins Proteom; 2017 Sep; 1865(9):1195-1206. PubMed ID: 28642153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of Retinoic Acid Receptor Subtypes by 5- and 8-Substituted (Naphthalen-2-yl)-based Arotinoids.
    Álvarez S; Lieb M; Martínez C; Khanwalkar H; Rodríguez-Barrios F; Álvarez R; Gronemeyer H; de Lera AR
    ChemMedChem; 2015 Aug; 10(8):1378-91. PubMed ID: 26012882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pattern of retinoid-induced teratogenic effects: possible relationship with relative selectivity for nuclear retinoid receptors RAR alpha, RAR beta, and RAR gamma.
    Elmazar MM; Reichert U; Shroot B; Nau H
    Teratology; 1996 Mar; 53(3):158-67. PubMed ID: 8761883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conformationally defined 6-s-trans-retinoic acid analogs. 3. Structure-activity relationships for nuclear receptor binding, transcriptional activity, and cancer chemopreventive activity.
    Muccio DD; Brouillette WJ; Alam M; Vaezi MF; Sani BP; Venepally P; Reddy L; Li E; Norris AW; Simpson-Herren L; Hill DL
    J Med Chem; 1996 Sep; 39(19):3625-35. PubMed ID: 8809153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specific antagonist of retinoid toxicity in mice.
    Standeven AM; Johnson AT; Escobar M; Chandraratna RA
    Toxicol Appl Pharmacol; 1996 May; 138(1):169-75. PubMed ID: 8658506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of retinoic acid receptor alpha in the stimulation of tissue-type plasminogen-activator gene expression in human endothelial cells.
    Kooistra T; Lansink M; Arts J; Sitter T; Toet K
    Eur J Biochem; 1995 Sep; 232(2):425-32. PubMed ID: 7556191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antagonists of retinoic acid receptors (RARs) are potent growth inhibitors of prostate carcinoma cells.
    Hammond LA; Van Krinks CH; Durham J; Tomkins SE; Burnett RD; Jones EL; Chandraratna RA; Brown G
    Br J Cancer; 2001 Aug; 85(3):453-62. PubMed ID: 11487280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new class of potent RAR antagonists: dihydroanthracenyl, benzochromenyl and benzothiochromenyl retinoids.
    Vuligonda V; Standeven AM; Escobar M; Chandraratna RA
    Bioorg Med Chem Lett; 1999 Mar; 9(5):743-8. PubMed ID: 10201840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ligand-dependent activation of transcription in vitro by retinoic acid receptor alpha/retinoid X receptor alpha heterodimers that mimics transactivation by retinoids in vivo.
    Dilworth FJ; Fromental-Ramain C; Remboutsika E; Benecke A; Chambon P
    Proc Natl Acad Sci U S A; 1999 Mar; 96(5):1995-2000. PubMed ID: 10051583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation of retinoid binding affinity to retinoic acid receptor alpha with retinoid inhibition of growth of estrogen receptor-positive MCF-7 mammary carcinoma cells.
    Dawson MI; Chao WR; Pine P; Jong L; Hobbs PD; Rudd CK; Quick TC; Niles RM; Zhang XK; Lombardo A
    Cancer Res; 1995 Oct; 55(19):4446-51. PubMed ID: 7671258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A retinoic acid receptor alpha antagonist counteracts retinoid teratogenicity in vitro and reduced incidence and/or severity of malformations in vivo.
    Eckhardt K; Schmitt G
    Toxicol Lett; 1994 Feb; 70(3):299-308. PubMed ID: 8284797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis of high specific activity [3H]-9-cis-retinoic acid and its application for identifying retinoids with unusual binding properties.
    Boehm MF; McClurg MR; Pathirana C; Mangelsdorf D; White SK; Hebert J; Winn D; Goldman ME; Heyman RA
    J Med Chem; 1994 Feb; 37(3):408-14. PubMed ID: 8308867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of retinoid-induced differentiation in embryonal carcinoma PCC4.aza1R cells: effects of retinoid-receptor selective ligands.
    Mills KJ; Vollberg TM; Nervi C; Grippo JF; Dawson MI; Jetten AM
    Cell Growth Differ; 1996 Mar; 7(3):327-37. PubMed ID: 8838863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.